claim
Senescent human pre-adipocytes or mesenchymal stem cells (MSCs) are susceptible to Dasatinib but not quercetin or fisetin, whereas senescent human umbilical vein endothelial cells (HUVECs) are susceptible to quercetin or fisetin but not Dasatinib.

Authors

Sources

Referenced by nodes (2)